TEL: (+62) 21 5890 1590
Venus Concept is a leader in the global medical and aesthetic device market, pairing best-in-class technology with the first and only true subscription model in the industry.
Hair restoration is an exciting and lucrative segment of the aesthetics industry and a robust addition to any clinic’s offerings. Although hair loss affects both men and women, each demographic has unique needs that you must acknowledge and address in order to cater to the growing demand for this life-changing treatment. Below, we explore the complexities of female hair loss in today’s market that you need to know for your clinic’s success.
The total market for hair restoration treatments has increased 16% since 2016 and it is now a $4.9 billion industry. Last year alone, over 700,000 procedures were performed worldwide. The same International Society of Hair Restoration Surgery reports that only 16% of those procedures were performed on women, a number which allows us to draw three conclusions. First, that women spent approximately $784 million on hair restoration last year. Second, that the market is growing, up from just 12% the previous year. Third, that there is still hesitation among women to get a hair restoration procedure, which could be due to the simple fact that hair restoration is still, in large part, marketed solely to men. From this, we can expect that any clinic that puts effort into marketing hair restoration towards women will have the advantage of attracting an overlooked demographic.
Female hair loss can be due to a variety of factors, including genetics, lifestyle changes, certain medications, or post-pregnancy. In some cases, the hair loss is temporary. In cases where the hair loss is permanent, only a hair restoration procedure will revive the lost hair. Recently, studies have shown that women who have had COVID-19 are experiencing hair loss for months after recovering from the virus. Anecdotal reports from recovering patients, including celebrities like Alyssa Milano, further these claims. For now, it appears that post-COVID-19 has to do with the three stages of hair growth and that the shedding may be temporary, with the hair returning to normal growth after a period of time. However, COVID-19 hair loss brings up an opportunity to open up a discussion about female hair loss, and to invite women into your clinic to discuss their concerns. If their hair loss is more severe, permanent, or continues long after COVID-19, then a hair restoration procedure is the answer.
According to one study by the American Academy of Dermatology, 40% of women will experience noticeable hair loss by the age of 40. It isn’t difficult to imagine the toll that female hair loss can take on self-esteem. In many cultures, a full head of hair denotes not only good health, but also social status, youth, and beauty. In men, hair loss takes such a huge bite out of confidence that it has been shown to affect self-perception and interpersonal relationships—for women it’s no different. This is reflected in a survey uncovering that the most common reasons for patients seeking hair restoration among patients were ‘social/dating’ (37%), followed by ‘career/professional’ (34%). Because female hair loss can have such an impact on self-esteem, saying that hair restoration can be life-changing is no overstatement.
Many women experiencing hair loss or thinning thinking that over-the-counter options or styling their hair differently are their only options. This is because most hair loss solutions are marketed to men. With the stigma of hair loss and a lack of clear marketing, female patients are at a disadvantage when searching for someone to turn to for advice. That’s why positioning your clinic as an expert in female hair restoration could put you at an advantage over your competitors. There is a better option for permanent hair restoration specifically designed with female hair loss in mind: NeoGraft®.
NeoGraft® is the latest generation in hair restoration devices, using automated FUE in a process that requires no stitches, leaves no visible scarring, and delivers a more natural-looking result. The procedure uses your own existing hair, transplanting healthy follicles through precision micrografts that cause little to no discomfort during the procedure, and require little downtime. After some initial tenderness in the first 2-3 days, most people return to regular activities. The transplanted hair will look natural, grow at the same rate as the surrounding hair, and should last for life.
Recently, we followed Jessi’s journey as she underwent a NeoGraft® hair restoration procedure. Her experience sums up what we’ve learned about the complexities of female hair loss. When she began to notice her hair thinning after having children, she turned to over-the-counter and styling to cover it up. “I tried vitamins, shampoos, spray fibers—all of that stuff only helps the hair you have. It doesn’t grow new hair.” That’s when her friend recommended, she look into hair restoration, and she found out about NeoGraft®. As little as 18 months after the procedure, she booked her first salon appointment in ages. “Now that my hair is all grown, I feel like I can do any hairstyle. People are telling me how awesome and full my hair looks.”
You can offer the same transformative experience that Jessi experienced with NeoGraft to your patients. Reach out to one of our experts today to learn more.
For more information call: (+62 21) 5890 1590 // info.id@venusconcept.com // Ruko Business Park Kebon Jeruk Blok B11 Jl. Meruya Ilir Raya No. 88 Kel. Meruya Utara, Kec. Kembangan West Jakarta 11620
REGULATORY CLEARANCES [ More ]
All devices have received Indonesian Health Ministry Approval for sale and use in Indonesia. (Izin Edar Alat Kesehatan)
Venus Versa™ is cleared by the FDA, licensed by Health Canada, and has CE Mark as a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 applicators are cleared by the FDA, licensed by Health Canada, and have CE Mark for the treatment of benign pigmented epidermal and cutaneous lesions and treatment of benign cutaneous vascular lesions. The HR650/HR650XL and HR690/HR690XL applicators are cleared by the FDA, licensed by Health Canada, and have CE Mark for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for Fitzpatrick skin types I-IV. The AC Dual applicator is cleared by the FDA, licensed by Health Canada, and has CE Mark for the treatment of acne vulgaris. The DiamondPolar™ and OctiPolar™ applicators on the Venus Versa™ system are cleared by the FDA for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The DiamondPolar™ applicator is licensed by Health Canada and has CE Mark for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The OctiPolar™ applicator on the Venus Versa™ system is licensed by Health Canada and has CE Mark for temporary body contouring via skin tightening, circumferential reduction, and cellulite reduction. The NanoFractional RF™ (Viva) applicator is cleared by the FDA, licensed by Health Canada, and has CE Mark for dermatological procedures requiring ablation and resurfacing of the skin.
Venus Legacy™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV with the OctiPolar™ and DiamondPolar™ applicators, and temporary reduction in the appearance of cellulite with the 4D Body (LB2) and 4D Face (LF2) applicators. It is licensed by Health Canada and has CE Mark for the temporary increase of skin tightening, temporary circumferential reduction, temporary cellulite reduction, and temporary wrinkle reduction.
Venus Viva™ is cleared by the FDA, licensed by Health Canada, and has CE Mark for dermatological procedures requiring ablation and resurfacing of the skin. The DiamondPolar™ applicator is licensed by Health Canada and has CE Mark for the treatment of moderate to severe wrinkles and rhytides in Fitzpatrick skin types I-IV.
Venus Freeze Plus™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV. It is licensed by Health Canada for temporary skin tightening, and temporary reduction in the appearance of stretch marks at the abdomen and flanks, using the DiamondPolar™ and OctiPolar™ applicators. The DiamondPolar™ applicator on Venus Freeze Plus™ has CE Mark for the non-invasive treatment of moderate to severe facial wrinkles and rhytides, and the increase of skin tightening, temporary circumferential reduction, and cellulite reduction with the OctiPolar™ applicator.
Venus Glow™ is cleared by the FDA as a Class I motorized dermabrasion device. It provides a dermal rejuvenation treatment that works to open up and deep-clean pores. Venus Concept is the exclusive distributor for Venus Glow™.
Copyright © 2018 Venus Concept. All rights reserved.
You are entering our website. For other countries/regions and language options, please click the SELECT A DIFFERENT REGION button below.
SELECT A DIFFERENT REGIONAre you looking to get a treatment? Please visit our patient website to learn more.
Click Here